Stock Analysis

Subdued Growth No Barrier To Groupe Bruxelles Lambert SA's (EBR:GBLB) Price

ENXTBR:GBLB
Source: Shutterstock

It's not a stretch to say that Groupe Bruxelles Lambert SA's (EBR:GBLB) price-to-sales (or "P/S") ratio of 1.3x right now seems quite "middle-of-the-road" for companies in the Diversified Financial industry in Belgium, where the median P/S ratio is around 1x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.

View our latest analysis for Groupe Bruxelles Lambert

ps-multiple-vs-industry
ENXTBR:GBLB Price to Sales Ratio vs Industry June 8th 2024

How Groupe Bruxelles Lambert Has Been Performing

Groupe Bruxelles Lambert could be doing better as its revenue has been going backwards lately while most other companies have been seeing positive revenue growth. It might be that many expect the dour revenue performance to strengthen positively, which has kept the P/S from falling. If not, then existing shareholders may be a little nervous about the viability of the share price.

If you'd like to see what analysts are forecasting going forward, you should check out our free report on Groupe Bruxelles Lambert.

Is There Some Revenue Growth Forecasted For Groupe Bruxelles Lambert?

In order to justify its P/S ratio, Groupe Bruxelles Lambert would need to produce growth that's similar to the industry.

Retrospectively, the last year delivered a frustrating 18% decrease to the company's top line. As a result, revenue from three years ago have also fallen 1.3% overall. Accordingly, shareholders would have felt downbeat about the medium-term rates of revenue growth.

Turning to the outlook, the next year should bring diminished returns, with revenue decreasing 17% as estimated by the only analyst watching the company. Meanwhile, the broader industry is forecast to expand by 3.8%, which paints a poor picture.

With this in consideration, we think it doesn't make sense that Groupe Bruxelles Lambert's P/S is closely matching its industry peers. Apparently many investors in the company reject the analyst cohort's pessimism and aren't willing to let go of their stock right now. There's a good chance these shareholders are setting themselves up for future disappointment if the P/S falls to levels more in line with the negative growth outlook.

What We Can Learn From Groupe Bruxelles Lambert's P/S?

We'd say the price-to-sales ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.

Our check of Groupe Bruxelles Lambert's analyst forecasts revealed that its outlook for shrinking revenue isn't bringing down its P/S as much as we would have predicted. With this in mind, we don't feel the current P/S is justified as declining revenues are unlikely to support a more positive sentiment for long. If the poor revenue outlook tells us one thing, it's that these current price levels could be unsustainable.

Before you take the next step, you should know about the 3 warning signs for Groupe Bruxelles Lambert (1 doesn't sit too well with us!) that we have uncovered.

If these risks are making you reconsider your opinion on Groupe Bruxelles Lambert, explore our interactive list of high quality stocks to get an idea of what else is out there.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.